21Doctors
Category: AI in Healthcare
An AI-powered healthtech company building a medical infrastructure tailored for the Arabic-speaking world. 21Doctors was founded in 2022. The company is led by Osama Almabroum. Based in Riyadh, Saudi Arabia. Team size: 10-50. Total funding raised: Undisclosed. Latest round: Pre-Seed (Undisclosed, Sep 2025). Key investors include Strategic Angel Investors.
- Founded
- 2022
- Headquarters
- Riyadh, Saudi Arabia
- Team size
- 10-50
- Total funding
- Undisclosed
Value proposition
To provide a digital-first healthcare platform that addresses the linguistic, cultural, and operational needs of the Arabic-speaking market, bridging a critical gap in global healthcare technology.
Products and solutions
A platform for continued medical education for healthcare professionals., An AI-powered tool for medical scribing specifically designed for the Arabic language., A connectivity platform for medical professionals and healthcare institutions.
Unique value
The company's primary focus is on the Arabic language, developing a specialized AI that understands complex Arabic medical terminology and dialects, a niche largely underserved by existing global healthtech solutions.
Target customer
Healthcare providers, medical institutions, and medical professionals in the Middle East and North Africa (MENA) region.
Industries served
Healthcare, Healthtech, Medical Education
Technology advantage
The development of an Arabic-first AI provides a significant competitive advantage in the MENA region, enabling the delivery of more accurate, efficient, and culturally relevant healthcare solutions.
How they differentiate
21Doctors is creating a digital-first healthcare platform designed specifically for the linguistic, cultural, and operational needs of Arabic-speaking markets. Their core differentiation is building an Arabic-first AI-powered medical infrastructure.
Main competitors
Altibbi, Vezeeta, Okadoc
Key partnerships
While specific partners have not been publicly named, the company is actively working on expanding its partnerships across the Gulf region, aligning with strategic initiatives like Saudi Arabia's Vision 2030.
Notable customers
Not publicly available
Major milestones
Successfully closed a pre-seed funding round to build its AI-powered healthcare infrastructure., Early traction in Jordan and Saudi Arabia.
Growth metrics
Not publicly available
Market positioning
21Doctors is positioning itself as a regional leader in Arabic-focused digital healthcare innovation.
Geographic focus
The company has early traction in Jordan and Saudi Arabia and is positioning itself as a regional leader in the MENA region.
Patents and IP
No publicly available information on patents.
About Osama Almabroum
Co-Founder & Business Development Lead at DawaDose, a pharmaceutical e-commerce startup. Holds a Bachelor's degree in Pharmacy.
Official website: https://21doctors.com/